Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
주식 순위 #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
주가
$0.089
마지막 동기화: 2026-08-17
시가총액
$15.36M
변동 (1일)
50.59%
변동 (1년)
111.85%
국가
US
거래 Inhibitor Therapeutics, Inc. (INTI)

카테고리

Inhibitor Therapeutics, Inc. (INTI)의 주식 분할 이력
Inhibitor Therapeutics, Inc. 주식 (심볼: INTI)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 18, 2026에 발생했습니다.
Aug 18, 2026 이전에 매수한 INTI 주식 1주는 현재 0주의 INTI 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE